EligibleTrials

China HeadAche DIsorders RegiStry

Recruiting · NCT05334927 · Observational (researchers observe without assigning treatment) · Lead sponsor: Beijing Tiantan Hospital

View the official record on ClinicalTrials.gov →
Migraine

Interventions studied

Episodic Migraine and Chronic MigraineEptinezumabErenumabMedicine Overuse Headache/New Daily Persistent HeadachePatients with other types of primary headacheYangxue Qingnao Granules (Pills)

What this trial is about

It is planned to include 10000 patients. In the China HeadAche DIsorders RegiStry CHAIRS), patients aged over 12 years with primary headache and medication-overuse headache(MOH) were collected. The biomarkers, imaging features, cognition, genetic characteristics, ocial and demographic data, medical data, therapeutics used, and outcome of headache-related diseases were studied, and long-term follow-up was planned.

Who can take part

Age range
12 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed.

Showing 60 of 61 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.